tci Medicare Compliance & Reimbursement - 2010 Issue 11
Payment Trends: Is the New Drug Sample Reporting Requirement a Message on the Wall for Pharma?
HHS could use the data it collects from drug companies to answer this key question. Starting in 2012, drug companies must fork over annual reports to HHS spelling out the types and volumes of drug samples they've tendered to individual physicians. And that data could open a window into a world that the government may be hankering to analyze. Baltimore attorney Joshua Freemire thinks the reporting requirement, which is mandated by the healthcare reform legislation, could be designed to give "federal authorities the data they need to assess how the free sample system affects prescription patterns." (He emphasizes...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Thank you for choosing Find-A-Code, please Sign In to remove ads.